Items tagged with Drug-resistant TB
Tuberculosis: Daily antibiotics recommended to prevent resistant strains (post)
A computer model of tuberculosis has shown that approved treatments prescribing antibiotic doses once or twice a week are more likely to lead to drug resistant strains than are daily antibiotic regimens.
Webinar: The race is on: Faster turnaround times in the diagnosis of multidrug-resistant tuberculosis (post)
In 2014, the Centers for Disease Control reported 9,412 new cases of tuberculosis (TB) – more than 9,000 too many! TB elimination is defined as 1 case per million population and with an estimated population in the United States (July 2014) of almost 319 million, this would result in only 319 cases – we have a long way to go in order to reach this ambitious goal.
Drug susceptibility patterns in MDR-TB patients: Challenges for future regimen design. A cross-sectional study (post)
Abstract
Death during MDR-TB treatment more likely in people with HIV and underweight or most drug-resistant patients (post)
People living with HIV, those who are underweight and those with more extensive drug resistance are more likely to die during treatment for multidrug-resistant tuberculosis (MDR-TB), a nine-country study has found. The findings were presented at the 46th Union World Conference on Lung Health in Cape Town last week.
Improved diagnosis and treatment of multidrug-resistant tuberculosis should be highly prioritized (post)
Patients with multidrug-resistant tuberculosis are more likely to have developed the disease through incidence transmission, rather than a new treatment-related acquisition, according to recent research published in The Lancet.
US: Only 3 congressmen showed for a hearing on the No. 1 infectious killer in the world (post)
Dr. Tom Frieden, director of the Centers for Disease Control and Prevention, was there. Dr. Eric Goosby, the United Nations envoy for tuberculosis, was there. Dr. Ariel Pablo-Mendez, the U.S. Agency for International Development's assistant administrator for global health, was there.
Waking up to the realities of drug-resistant tuberculosis in children (post)
In my more than 13 years as a tuberculosis (TB) researcher and pediatrician, there is one prevailing trend that has increasingly troubled me: people, especially individuals in the U.S., like to believe that TB is no longer an important issue. This misperception is dangerous, especially when one accounts for its growing resistance to drugs and the difficulties of diagnosing and treating TB, especially in children.
Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt (post)
Abstract
International consensus statement on molecular diagnosis of tuberculosis drug-resistance released (post)
Multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) are challenging tuberculosis control globally. Early identification of patients with MDR-TB and XDR-TB and the complex pattern of Mycobacterium tuberculosis drug resistance are key to providing each individual patient with the correct therapy. Traditionally, identification of the spectrum of bacillary drug resistance takes several weeks to a few months, leading to under-treatment or incorrect treatment in many cases.
Software program aims to rapidly identify drug resistance from bacterial genome sequences (post)
NEW YORK, December 21, 2015 – A University of Oxford-led team of researchers has developed a computer program to rapidly detect antibiotic resistance from bacterial genome sequences.
Page 22 of 117 · Total posts: 0
←First 21 22 23 Last→